Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    12223530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass
Conditions: Heart Diseases;   Postoperative Complications
Intervention: Drug: INO-1001
2 Available Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation;   Triple-Negative Breast Cancer
Interventions: Drug: Veliparib;   Drug: Cisplatin;   Drug: Vinorelbine

Study has passed its completion date and status has not been verified in more than two years.